Insider · CIK 0001362155
Earl Martin Douglas
Files at ALLO (Allogene Therapeutics, Inc.). First filing Feb 5, 2025, latest Feb 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALLO: Allogene Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Allogene Therapeutics, Inc. | $11k 6,404 shares | -1% | 0% from low-48% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | ALLO Allogene Therapeutics, Inc. | SOpen-market sale Common Stock | -6,404 | $1.71 | $11k | 587,848 | Feb 5, 2025 |
| Jan 24, 2025 | ALLO Allogene Therapeutics, Inc. | AGrant or award Common Stock | +144,928 | $0.00 | $0 | 594,252 | Jan 28, 2025 |
| Jan 24, 2025 | ALLO Allogene Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +512,370 | $0.00 | $0 | 512,370 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.